Chloroquine and hydroxychloroquine-related ocular adverse events in SLE treatment: a real-world disproportionality analysis based on FDA adverse event reporting system (FAERS)

Chloroquine and hydroxychloroquine-related ocular adverse events in SLE treatment: a real-world disproportionality analysis based on FDA adverse event reporting system (FAERS)

ObjectiveThis study aimed to evaluate the risk of adverse events associated with chloroquine (CQ) and hydroxychloroquine (HCQ) in patients with systemic lupus erythematosus (SLE), using data from the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS).MethodsDisproportionality a...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiang Li, Si-Qi Zhang, Ke-Rui Wang, Shi-Nan Wu, Meng-Yuan Wang, Cui-Ting Chen, Nuo Dong
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Pharmacology
Subjects:
cloroquine
hydroxychloroquine
ocular adverse events
FAERS
systemic lupus erythematosus
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1498814/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items